Development
Dolby Laboratories, Inc.
DLB
$71.98
-$0.36-0.50%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 629.16% | -43.98% | -82.86% | 20.56% | 185.97% |
| Total Depreciation and Amortization | -13.59% | -0.19% | -1.17% | 9.97% | -0.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.70% | 47.89% | 87.52% | -10.48% | -32.50% |
| Change in Net Operating Assets | -2,026.41% | -89.23% | 251.48% | 49.31% | -140.23% |
| Cash from Operations | -90.11% | -29.81% | 15.87% | 85.37% | 9.91% |
| Capital Expenditure | 25.49% | -10.41% | 1.48% | -4.25% | 32.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 158.41% | -408.10% | -87.97% | -12.41% | 218.34% |
| Cash from Investing | 103.21% | -189.47% | -6.59% | -16.66% | 169.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.31% | -33.38% | 51.70% | -4.69% | 157.86% |
| Repurchase of Common Stock | -316.22% | -2.63% | 48.09% | 30.57% | 66.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.57% | 0.08% | 0.11% | -0.01% | -6.67% |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -192.40% | -16.22% | 45.12% | 25.53% | 62.84% |
| Foreign Exchange rate Adjustments | 283.56% | -520.64% | -165.42% | -89.29% | 220.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -681.21% | -82.21% | 70.70% | 1,894.30% | 101.30% |